Developer of inhaled drug delivery devices to deliver a broad range of pharmaceuticals. The company's products include "RespiRx" a combination drug product for first inhalable prescription NRT (Nicotine Replacement Therapy) for smokers trying to quit smoking and a vibrating mesh nebulizer for optimal delivery to the lungs.
← All startups
Qnovia
Series BDeveloper of inhaled drug delivery devices to deliver a broad range of pharmaceuticals. The company's products include "RespiRx" a combination drug product for first inhalable prescription NRT (Nicotine Replacement Therapy) for smokers trying to quit smoking and a vibrating mesh nebulizer for optimal delivery to the lungs.
About
Institutional investors
Blue Ledge CapitalEvolution VC PartnersVice VenturesGaingelsDG VenturesTL Capital Holdings
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Backed by funds in our directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.